Worth Seeing!
Invest in Cases Systematically - Every stock is handpicked Start Buying Now Start Buying Now
mw4me logo
Talk to Us | Subscribe | Advisory Services
Sensex 74005.94
88.91 (0.12%)

BSE Healthcare Companies

Read More Read Less

The BSE Healthcare Index is designed to reflect the behaviour and performance of mid market capitalization companies. S&P BSE Mid Cap includes all companies forming part of mid cap universe on BSE. Look for Green and Orange companies for investing. Bookmark this page for your easy reference in future.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen:- Q: Quality, V: Valuation,PT: Price Trend

Filter
BSE Healthcare companies as on May-2024 |
Filter

 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks


Company Name (M.Cap)
DeciZen


CMP


Price
Change


Market
Cap (Cr)


52Week
High


52Week
Low


ROE


P/E


P/BV


EV/
EBITDA


5Y Sales
Gr.(%)


5Y Profit
Gr.(%)
More Info
1
Sigachi Industries Ltd
(S)
Q V+ PT
69.11 5.00% 2,268 95.94
27 Feb, 24		 23.30
26 May, 23		 15.90 58.59 5.32 34.59 23.28 32.58
2
Zydus Lifesciences Ltd
(L)
Q V PT
1,104 5.00% 1,11,134 1,104
18 May, 24		 482.6
22 May, 23		 10.18 28.79 5.60 19.55 7.68 -0.07
3
Concord Biotech Ltd
(S)
Q V PT
1,494 4.36% 15,639 1,712
30 Apr, 24		 900.0
18 Aug, 23		 19.26 65.14 10.94 40.59 0.00 0.00
4
Rainbow Childrens Medicare Ltd
(S)
Q V+ PT
1,389 3.64% 14,147 1,649
06 May, 24		 878.0
19 May, 23		 24.26 64.29 11.52 31.99 22.62 38.74
5
Aurobindo Pharma Ltd
(M)
Q V PT
1,204 3.44% 70,468 1,212
18 May, 24		 581.5
19 May, 23		 6.75 35.84 3.65 25.52 4.49 -7.93
6
Krishna Institute of Medical Sciences Ltd
(S)
Q V PT
1,956 3.37% 15,633 2,357
29 Feb, 24		 1,513
22 May, 23		 16.79 66.43 8.38 41.95 12.50 0.00
7
Unichem Laboratories Ltd
(S)
Q V PT
561.0 3.23% 3,927 616.0
06 May, 24		 365.4
27 Jun, 23		 -12.12 0.00 1.63 102.99 9.99 0.00
8
Vijaya Diagnostic Centre Ltd
(S)
Q V+ PT
800.0 3.19% 8,282 838.0
15 May, 24		 367.1
22 May, 23		 16.70 69.70 12.60 33.96 0.00 0.00
9
Glaxosmithkline Pharmaceuticals Ltd
(M)
Q V+ PT
2,358 2.90% 39,908 2,650
09 Feb, 24		 1,275
22 May, 23		 26.60 67.64 22.45 37.67 2.52 11.21
10
Innova Captab Ltd
(S)
Q V PT
516.1 2.84% 2,969 590.0
19 Jan, 24		 444.0
28 Mar, 24		 22.99 51.59 3.25 30.59 0.00 0.00
11
Sastasundar Ventures Ltd
(S)
Q V PT
298.2 2.35% 944 506.4
22 Nov, 23		 252.0
07 Aug, 23		 0.24 0.00 3.46 2536.08 -100.00 -43.78
12
Glenmark Pharmaceuticals Ltd
(S)
Q V PT
1,043 2.30% 29,407 1,098
29 Apr, 24		 581.2
22 May, 23		 1.26 0.00 3.31 21.88 7.44 -31.19
13
Morepen Laboratories Ltd
(S)
Q V PT
47.95 2.28% 2,447 56.35
20 Feb, 24		 25.34
29 May, 23		 6.71 30.12 2.87 18.27 19.01 9.18
14
Gujarat Themis Biosyn Ltd
(S)
Q V+ PT
412.9 2.20% 2,978 435.0
06 May, 24		 145.8
26 May, 23		 45.92 50.33 14.79 35.73 30.87 72.01
15
Lincoln Pharmaceuticals Ltd
(S)
Q V+ PT
589.5 2.18% 1,158 754.2
26 Feb, 24		 365.4
30 May, 23		 13.85 12.41 1.95 8.53 9.45 16.46
16
Blue Jet Healthcare Ltd
(S)
Q V+ PT
369.0 1.85% 6,384 433.2
02 Nov, 23		 319.4
12 Dec, 23		 24.80 39.90 3.89 25.97 0.00 0.00
17
Themis Medicare Ltd
(S)
Q V+ PT
213.9 1.74% 1,969 266.0
02 Mar, 24		 131.3
04 Jul, 23		 15.62 79.57 7.35 36.34 11.08 34.06
18
Supriya Lifescience Ltd
(S)
Q V+ PT
382.6 1.58% 3,068 423.5
25 Apr, 24		 231.1
17 Jul, 23		 13.68 25.48 3.92 16.12 16.71 67.00
19
Vimta Labs Ltd
(S)
Q V+ PT
501.0 1.40% 1,111 621.4
25 Aug, 23		 365.0
19 May, 23		 18.06 28.62 3.65 12.61 11.43 22.79
20
FDC Ltd
(S)
Q V+ PT
485.0 1.39% 7,857 491.2
18 May, 24		 281.4
22 May, 23		 9.72 26.53 3.83 18.35 10.84 3.42
21
Bliss GVS Pharma Ltd
(S)
Q V+ PT
111.0 1.32% 1,156 148.9
28 Nov, 23		 71.00
23 May, 23		 6.53 22.83 1.17 7.48 14.97 1.73
22
Suven Life Sciences Ltd
(S)
Q V PT
100.4 1.26% 2,192 128.8
12 Jan, 24		 55.01
31 May, 23		 -3.63 0.00 2.59 -207.83 -53.54 -163.87
23
Medicamen Biotech Ltd
(S)
Q V PT
537.0 1.23% 683 903.5
11 Aug, 23		 356.8
13 Mar, 24		 8.17 47.94 3.39 24.91 4.34 7.42
24
IOL Chemicals And Pharmaceuticals Ltd
(S)
Q V+ PT
378.4 1.12% 2,213 535.6
15 Sep, 23		 350.3
14 Mar, 24		 9.28 16.46 1.37 8.07 0.00 0.00
25
Syncom Formulations (India) Ltd
(S)
Q V+ PT
13.58 1.04% 1,277 18.65
09 Jan, 24		 6.23
26 May, 23		 7.19 54.03 4.62 31.26 7.21 10.35
26
Mankind Pharma Ltd
(L)
Q V PT
2,115 1.02% 84,596 2,489
23 Apr, 24		 1,241
22 May, 23		 17.18 46.39 8.79 32.35 15.71 13.53
27
Novartis India Ltd
(S)
Q V+ PT
1,113 0.98% 2,763 1,224
19 Feb, 24		 600.0
26 Oct, 23		 14.17 32.43 3.71 17.07 -7.65 9.95
28
Jagsonpal Pharmaceuticals Ltd
(S)
Q V+ PT
360.9 0.97% 955 513.9
31 Jul, 23		 270.1
14 Mar, 24		 18.41 38.96 5.33 23.97 13.35 0.00
29
Granules India Ltd
(S)
Q V PT
405.5 0.92% 9,856 480.5
26 Feb, 24		 272.0
25 May, 23		 19.30 22.61 3.17 13.23 19.01 31.51
30
Max Healthcare Institute Ltd
(M)
Q V+ PT
847.8 0.85% 82,180 909.0
13 Feb, 24		 505.4
06 Jun, 23		 16.09 77.75 10.10 49.83 21.42 0.00
31
Laurus Labs Ltd
(S)
Q V PT
443.6 0.84% 23,957 470.9
10 Apr, 24		 307.4
19 May, 23		 21.71 149.22 5.83 32.75 24.05 38.61
32
Pfizer Ltd
(S)
Q V PT
4,438 0.78% 20,467 4,940
27 Mar, 24		 3,730
23 Jun, 23		 19.73 37.12 5.69 22.58 4.26 11.01
33
Yatharth Hospital & Trauma Care Services Ltd
(S)
Q V+ PT
449.4 0.71% 3,844 503.9
28 Feb, 24		 304.0
07 Aug, 23		 44.59 59.90 4.74 32.90 0.00 0.00
34
Eris Lifesciences Ltd
(S)
Q V PT
892.5 0.69% 12,206 971.0
09 Nov, 23		 605.2
22 May, 23		 18.45 31.58 4.86 19.57 14.52 6.67
35
Kovai Medical Center & Hospital Ltd
(S)
Q V+ PT
4,062 0.69% 4,450 4,272
26 Apr, 24		 1,968
19 May, 23		 17.66 28.14 5.33 13.69 11.48 15.15
36
Ipca Laboratories Ltd
(M)
Q V+ PT
1,311 0.63% 33,258 1,374
18 Apr, 24		 670.0
22 May, 23		 8.97 60.42 5.24 29.09 12.58 17.37
37
JB Chemicals & Pharmaceuticals Ltd
(S)
Q V+ PT
1,835 0.61% 28,566 1,935
07 Feb, 24		 914.6
22 May, 23		 17.33 52.57 9.90 31.56 18.11 31.92
38
Wockhardt Ltd
(S)
Q V PT
549.6 0.59% 8,431 630.0
01 Mar, 24		 167.0
23 May, 23		 -11.93 0.00 2.40 50.24 -7.60 0.00
39
Hikal Ltd
(S)
Q V PT
299.8 0.57% 3,678 331.1
22 Apr, 24		 258.6
02 Nov, 23		 6.95 52.85 3.10 16.59 9.31 -0.88
40
Lupin Ltd
(M)
Q V PT
1,662 0.57% 75,652 1,704
11 Mar, 24		 766.0
24 May, 23		 2.93 39.52 5.29 19.62 1.04 9.19
41
Procter & Gamble Health Ltd
(S)
Q V PT
4,815 0.56% 7,993 5,640
12 Feb, 24		 4,640
09 May, 24		 33.46 37.35 9.38 23.50 11.99 36.80
42
Alembic Pharmaceuticals Ltd
(S)
Q V PT
965.0 0.52% 19,001 1,093
21 Feb, 24		 536.6
23 May, 23		 23.92 30.85 3.94 20.07 12.54 23.14
43
Poly Medicure Ltd
(S)
Q V+ PT
1,649 0.52% 15,915 1,727
21 Feb, 24		 945.0
22 May, 23		 14.89 63.23 10.91 39.10 16.00 20.25
44
Ajanta Pharma Ltd
(M)
Q V PT
2,392 0.51% 30,157 2,532
03 May, 24		 1,265
30 May, 23		 16.50 36.95 8.45 23.90 11.98 4.54
45
Abbott India Ltd
(M)
Q V+ PT
26,618 0.48% 56,616 29,628
16 Feb, 24		 20,594
19 May, 23		 31.69 47.13 15.31 32.02 10.15 20.60
46
Fortis Healthcare Ltd
(M)
Q V+ PT
453.0 0.47% 34,139 470.1
06 May, 24		 271.4
05 Jun, 23		 1.08 256.32 3.79 118.25 9.81 0.00
47
Sun Pharma Advanced Research Company Ltd
(S)
Q V+ PT
219.6 0.43% 7,123 474.0
09 Apr, 24		 178.1
26 May, 23		 -81.27 0.00 30.70 -19.74 24.99 0.00
48
Natco Pharma Ltd
(S)
Q V PT
999.4 0.43% 17,899 1,108
19 Feb, 24		 609.5
25 May, 23		 15.14 14.01 3.25 10.20 4.38 0.36
49
Indoco Remedies Ltd
(S)
Q V+ PT
321.1 0.42% 2,970 416.9
01 Jan, 24		 308.8
26 Oct, 23		 14.71 25.46 2.64 12.94 9.93 28.74
50
Suven Pharmaceuticals Ltd
(S)
Q V PT
645.0 0.41% 16,437 767.0
04 Jan, 24		 427.1
27 Jun, 23		 23.62 44.32 8.29 29.57 0.00 0.00
Prev 1
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×
Great Decisions Ensure Success

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Sigachi Industries
69.115%
Zydus Lifesciences
1,104.455%
Concord Biotech
1,493.904.36%
RainbowChildrenS Med
1,3893.64%
Aurobindo Pharma
1,203.903.44%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Shilpa Medicare
499.30-4.38%
Caplin Point Lab
1,313.05-1.90%
HealthcareGlobal
359.15-1.41%
Marksans Pharma
166.90-1.33%
Gland Pharma
1,768.35-1.31%
View More

News about BSE Healthcare

Vimta Labs - Quaterly Results

The revenue slipped marginally during the March 2024 quarter. A decline of about Rs. 783.38 millions was observed as compared to Rs. 808.03 millions during the corresponding quarter last year.The Company's Net profit for the March 2024 quarter have declined marginally to Rs. 118.01  millions as against Rs. 122.50 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 241.11 millions from 242.24 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 783.38 808.03 -3.05 3128.91 3151.16 -0.71 3128.91 3151.16 -0.71
Other Income 4.87 6.65 -26.77 40.10 34.68 15.63 40.10 34.68 15.63
PBIDT 241.11 242.24 -0.47 876.49 970.15 -9.65 876.49 970.15 -9.65
Interest 5.28 2.48 112.90 21.13 26.44 -20.08 21.13 26.44 -20.08
PBDT 235.83 239.76 -1.64 855.36 943.71 -9.36 855.36 943.71 -9.36
Depreciation 80.32 79.98 0.43 339.99 305.40 11.33 339.99 305.40 11.33
PBT 155.51 159.78 -2.67 515.37 638.31 -19.26 515.37 638.31 -19.26
TAX 37.50 37.28 0.59 127.30 165.32 -23.00 127.30 165.32 -23.00
Deferred Tax -9.30 -0.18 5066.67 -34.09 -22.37 52.39 -34.09 -22.37 52.39
PAT 118.01 122.50 -3.67 388.07 472.99 -17.95 388.07 472.99 -17.95
Equity 44.34 44.26 0.18 44.34 44.26 0.18 44.34 44.26 0.18
PBIDTM(%) 30.78 29.98 2.67 28.01 30.79 -9.01 28.01 30.79 -9.01
18 May, 2024

IOL Chemicals and Pharmaceuticals informs about loss of share certificate

Pursuant to Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that it has received letter regarding loss of share certificate and requesting the Company for issue of duplicate share certificate, from shareholder, as details enclosed.

The above information is a part of company’s filings submitted to BSE.


18 May, 2024

Zydus Lifesciences touches roof on reporting 3-fold jump in Q4 consolidated net profit

Total consolidated income of the company increased by 12.71% at Rs 5690.20 crore for Q4FY24
18 May, 2024

Pfizer - Quaterly Results

Revenue showed a marginal decline at Rs. 5466.30 millions. For the quarter ended March 2024, as compared to corresponding quarter of last year.The company has announced a 37.96% increase in its profits to Rs . 1788.60  millions for the  quarter ended March 2024 compared to Rs. 1296.50 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended March 2024 rose to 2645.60 millions as compared to 2132.50 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5466.30 5726.40 -4.54 21931.70 24247.60 -9.55 21931.70 24247.60 -9.55
Other Income 751.30 313.80 139.42 1805.10 1010.50 78.63 1805.10 1010.50 78.63
PBIDT 2645.60 2132.50 24.06 8158.10 9099.10 -10.34 8158.10 9099.10 -10.34
Interest 69.50 25.30 174.70 154.10 133.90 15.09 154.10 133.90 15.09
PBDT 2576.10 1911.30 34.78 8083.50 9295.20 -13.04 8083.50 9295.20 -13.04
Depreciation 137.50 264.10 -47.94 622.80 1055.10 -40.97 622.80 1055.10 -40.97
PBT 2438.60 1647.20 48.05 7460.70 8240.10 -9.46 7460.70 8240.10 -9.46
TAX 650.00 350.70 85.34 1947.40 2000.80 -2.67 1947.40 2000.80 -2.67
Deferred Tax 163.10 -315.30 -151.73 361.10 -519.10 -169.56 361.10 -519.10 -169.56
PAT 1788.60 1296.50 37.96 5513.30 6239.30 -11.64 5513.30 6239.30 -11.64
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 48.40 37.24 29.96 37.20 37.53 -0.87 37.20 37.53 -0.87
17 May, 2024

Syncom Formulations - Quaterly Results

A fair growth of 19.39% in the revenue at Rs. 732.66 millions was reported in the March 2024 quarter as compared to Rs. 613.69 millions during year-ago period.A slender decline of -20.30% was recorded to Rs. 67.47  millions from Rs. 84.66 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 116.75 millions from 127.17 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 732.66 613.69 19.39 2583.60 2246.44 15.01 2583.60 2246.44 15.01
Other Income 28.71 67.79 -57.65 131.01 146.10 -10.33 131.01 146.10 -10.33
PBIDT 116.75 127.17 -8.19 409.55 342.22 19.67 409.55 342.22 19.67
Interest 11.70 12.92 -9.44 44.49 31.30 42.14 44.49 31.30 42.14
PBDT 105.05 114.38 -8.16 364.82 311.05 17.29 364.82 311.05 17.29
Depreciation 12.98 11.68 11.13 47.22 45.39 4.03 47.22 45.39 4.03
PBT 92.07 102.70 -10.35 317.60 265.66 19.55 317.60 265.66 19.55
TAX 24.60 18.04 36.36 81.36 64.95 25.27 81.36 64.95 25.27
Deferred Tax 0.43 -7.84 -105.48 5.54 -1.53 -462.09 5.54 -1.53 -462.09
PAT 67.47 84.66 -20.30 236.24 200.71 17.70 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 15.94 20.72 -23.10 15.85 15.23 4.06 15.85 15.23 4.06
17 May, 2024

JB Chem & Pharma - Quaterly Results

A fair growth of 15.74% in the revenue at Rs. 8092.00 millions was reported in the March 2024 quarter as compared to Rs. 6991.40 millions during year-ago period.A comparatively good net profit growth of 41.93% to Rs. 1258.50 millions was reported for the quarter ended March 2024 compared to Rs. 886.70 millions of previous same quarter.Operating profit surged to 2111.50 millions from the corresponding previous quarter of 1647.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 8092.00 6991.40 15.74 32986.40 28841.60 14.37 32986.40 28841.60 14.37
Other Income 161.00 33.00 387.88 346.80 86.50 300.92 346.80 86.50 300.92
PBIDT 2111.50 1647.40 28.17 9141.00 6733.40 35.76 9141.00 6733.40 35.76
Interest 83.20 122.60 -32.14 405.20 343.10 18.10 405.20 343.10 18.10
PBDT 2028.30 1524.80 33.02 8735.80 6390.30 36.70 8735.80 6390.30 36.70
Depreciation 397.20 305.60 29.97 1352.40 1119.90 20.76 1352.40 1119.90 20.76
PBT 1631.10 1219.20 33.78 7383.40 5270.40 40.09 7383.40 5270.40 40.09
TAX 372.60 332.50 12.06 1949.80 1381.50 41.14 1949.80 1381.50 41.14
Deferred Tax 93.40 109.00 -14.31 494.90 548.00 -9.69 494.90 548.00 -9.69
PAT 1258.50 886.70 41.93 5433.60 3888.90 39.72 5433.60 3888.90 39.72
Equity 155.20 154.80 0.26 155.20 154.80 0.26 155.20 154.80 0.26
PBIDTM(%) 26.09 23.56 10.74 27.71 23.35 18.70 27.71 23.35 18.70
17 May, 2024
Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds
Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,821 20,331 37.01 18.76 23.75 51.69
Gujarat Themis Biosyn Ltd. (S) Very Good 412.9 2,978 50.33 14.79 35.73 45.92
Yatharth Hospital & Trauma Care Services Ltd. (S) Somewhat Good 449.4 3,844 59.90 4.74 32.90 44.59
Narayana Hrudayalaya Ltd. (S) Very Good 1,295 26,416 34.23 9.82 22.53 33.47
Procter & Gamble Health Ltd. (S) Very Good 4,815 7,993 37.35 9.38 23.50 33.46

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Global Health Ltd. (M) Very Good 1,409 37,747 150.4
Zydus Lifesciences Ltd. (L) Very Good 1,104 1,11,134 117.7
Lupin Ltd. (M) Somewhat Good 1,662 75,652 113.0
Piramal Pharma Ltd. (S) Not Good 149.3 19,785 111.6
Jubilant Pharmova Ltd. (S) Not Good 716.2 11,416 111.1
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Krsnaa Diagnostics Ltd. (S) Somewhat Good 595.4 1,936 37.27 2.50 12.33 38.65
Gujarat Themis Biosyn Ltd. (S) Very Good 412.9 2,978 50.33 14.79 35.73 30.87
AMI Organics Ltd. (S) Very Good 1,240 4,584 104.9 6.79 39.15 26.79
Sun Pharma Advanced Research Company Ltd. (S) Not Good 219.6 7,123 0.00 30.70 -19.74 24.99
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 24.05

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Kopran Ltd. (S) Not Good 249.8 1,202 34.71 2.88 22.70 217.3
Gujarat Themis Biosyn Ltd. (S) Very Good 412.9 2,978 50.33 14.79 35.73 72.01
Supriya Lifescience Ltd. (S) Somewhat Good 382.6 3,068 25.48 3.92 16.12 67.00
Narayana Hrudayalaya Ltd. (S) Very Good 1,295 26,416 34.23 9.82 22.53 62.83
Marksans Pharma Ltd. (S) Somewhat Good 166.9 7,559 63.75 6.36 39.31 59.01

Want to build you portfolio with best stocks today?

Check Now!
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.